Michel De Vos
Overview
Explore the profile of Michel De Vos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Van Der Kelen A, Keymolen K, Cools W, De Vos A, Polsler L, De Vos M, et al.
J Assist Reprod Genet
. 2024 May;
41(7):1907-1915.
PMID: 38753088
Purpose: Our objective is to predict the cumulative live birth rate (CLBR) and identify the specific subset within the population undergoing preimplantation genetic testing for monogenic disorders (PGT-M) and chromosomal...
12.
Macklon K, De Vos M
Reprod Biomed Online
. 2024 May;
49(1):103939.
PMID: 38733675
Fertility preservation is currently offered to young women with breast cancer to increase their chances of motherhood after a potentially gonadotoxic treatment. Ovarian stimulation with oocyte vitrification and cryopreservation of...
13.
Delbaere I, De Vos M, Somers S, Condorelli M, Pening D, Bogaerts A, et al.
Eur J Contracept Reprod Health Care
. 2024 Apr;
29(3):85-92.
PMID: 38683752
Purpose: In the past decades, a positive attitude towards having children has been reported in young people. The current generation of adolescents is increasingly concerned about environmental cataclysm which may...
14.
Adriaenssens T, Van Vaerenbergh I, Van Landuyt L, Verheyen G, De Brucker M, Camus M, et al.
PLoS One
. 2024 Jan;
19(1):e0297040.
PMID: 38295095
Research Question: Can a strategy for scoring oocyte quality, based on cumulus cell (CC) gene expression, prioritize oocytes with the highest implantation potential, while limiting the number of embryos to...
15.
Saucedo-Cuevas L, Ma M, Le A, Akin N, Pham T, Ho T, et al.
Fertil Steril
. 2023 Dec;
121(3):506-518.
PMID: 38052376
Objective: To investigate alterations of the global DNA methylation profile in placenta, cord blood, and neonatal buccal smears in infants conceived using in vitro maturation (IVM) with a prematuration step...
16.
Nauwynck E, De Schepper J, De Vos M, Staels W
JCEM Case Rep
. 2023 Dec;
1(6):luad124.
PMID: 38045866
Premature ovarian insufficiency (POI) is a rare cause of primary amenorrhea in adolescents. For young women with uncertain etiology of POI, genetic and autoimmune testing may be recommended to assist...
17.
Gilchrist R, Ho T, De Vos M, Sanchez F, Romero S, Ledger W, et al.
Hum Reprod Update
. 2023 Aug;
30(1):3-25.
PMID: 37639630
Background: While oocyte IVM is practiced sporadically it has not achieved widespread clinical practice globally. However, recently there have been some seminal advances in our understanding of basic aspects of...
18.
Juul A, Gravholt C, De Vos M, Koledova E, Cools M
Front Endocrinol (Lausanne)
. 2023 May;
14:1160884.
PMID: 37214245
Diagnosis and management of individuals who have differences of sex development (DSD) due to numerical or structural variations of sex chromosomes (NSVSC) remains challenging. Girls who have Turner syndrome (45X)...
19.
Santulli P, Blockeel C, Bourdon M, Coticchio G, Campbell A, De Vos M, et al.
Hum Reprod Open
. 2023 May;
2023(2):hoad012.
PMID: 37124950
Although a wealth of data has been published regarding fertility preservation (FP) in women with malignant diseases who receive gonadotoxic treatment, the role of FP in non-malignant conditions has been...
20.
Mackens S, Pais F, Drakopoulos P, Amghizar S, Roelens C, Van Landuyt L, et al.
Reprod Biomed Online
. 2023 Apr;
46(6):939-945.
PMID: 37012101
Research Question: Does additional supplementation with oral dydrogesterone improve reproductive outcomes in patients with low serum progesterone concentrations on the day of frozen embryo transfer (FET) after artificial (HRT) endometrial...